HighTower Advisors’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $411K | Sell |
1,357
-66
| -5% | -$20K | ﹤0.01% | 2686 |
|
|
2025
Q1 | $471K | Sell |
1,423
-54
| -4% | -$17.9K | ﹤0.01% | 2496 |
|
|
2024
Q4 | $456K | Sell |
1,477
-199
| -12% | -$61.4K | ﹤0.01% | 2527 |
|
|
2024
Q3 | $355K | Sell |
1,676
-108
| -6% | -$22.9K | ﹤0.01% | 2678 |
|
|
2024
Q2 | $499K | Buy |
1,784
+394
| +28% | +$110K | ﹤0.01% | 2308 |
|
|
2024
Q1 | $370K | Buy |
1,390
+487
| +54% | +$130K | ﹤0.01% | 2503 |
|
|
2023
Q4 | $208K | Buy |
+903
| New | +$208K | ﹤0.01% | 2958 |
|
|
2023
Q1 | – | Sell |
-720
| Closed | -$208K | – | 3210 |
|
|
2022
Q4 | $208K | Buy |
+720
| New | +$208K | ﹤0.01% | 2717 |
|